시판 백신접종 스트레스 완화제의 돼지 구제역 백신 접종부위 부작용 발생 저감 효과 평가
Evaluation of efficacy of a commercial vaccine stress-relieving agent to reduce the adverse effects of foot-and-mouth disease vaccination site in pig
1
조회
0
다운로드
10
인용
0
참고문헌
키워드
초록
In this study, we evaluated the efficacy of a commercial vaccine stress-relieving agent (Anti VS-2 injection) to reduce the adverse effects of foot-and-mouth disease (FMD) vaccination site in 120 pigs on two tested pig farms. The results showed that incidence of pig with abnormal meat, size of abnormal meat and weight of discarded abnormal meat are significantly decreased in Anti VS-2 injection- supplemented FMD vaccinated pig groups (n=60) compared to the non-supplemented FMD vaccinated pig groups (n=60) (P＜0.05). And the average economic loss by discard of abnormal meat were estimated 99,382 won or 21,514 won in the non-supplemented FMD vaccinated groups or in the Anti VS-2 injection-supplemented FMD vaccinated groups, respectively, showing that the cost saving effect was 78% (77,869 won). In conclusion, it is expected to reduce the incidence and severity of abnormal meat in the FMD vaccinated pigs and to contribute not only to the reduced economic loss of pig farmers but also to the promotion of food hygiene when the Anti VS-2 injection is mixed with FMD vaccine.
Abstract
In this study, we evaluated the efficacy of a commercial vaccine stress-relieving agent (Anti VS-2 injection) to reduce the adverse effects of foot-and-mouth disease (FMD) vaccination site in 120 pigs on two tested pig farms. The results showed that incidence of pig with abnormal meat, size of abnormal meat and weight of discarded abnormal meat are significantly decreased in Anti VS-2 injection- supplemented FMD vaccinated pig groups (n=60) compared to the non-supplemented FMD vaccinated pig groups (n=60) (P＜0.05). And the average economic loss by discard of abnormal meat were estimated 99,382 won or 21,514 won in the non-supplemented FMD vaccinated groups or in the Anti VS-2 injection-supplemented FMD vaccinated groups, respectively, showing that the cost saving effect was 78% (77,869 won). In conclusion, it is expected to reduce the incidence and severity of abnormal meat in the FMD vaccinated pigs and to contribute not only to the reduced economic loss of pig farmers but also to the promotion of food hygiene when the Anti VS-2 injection is mixed with FMD vaccine.
참고문헌 (29)
- 농림축산검역본부, "도축하는 가축 및 그 식육에 대한 세부검사기준", 농림축산검역본부고시 제2016-18호, ~ (2016)
- 박최규, "구제역 백신의 특성과 올바른 사용방법", 대한수의사회지, 48, pp.144~149 (2012)
- "동물약품 편람" (2017), 한국동물약품협회[URL]
- Aucouturier J, "Adjuvants designed for veterinary and human vaccines", Vaccine, 19, pp.2666~2672 (2001)
- Bahenmann HG, "Oil adjuvant vaccine against foot-and-mouth disease", Biol Centr Panam Fiebre, 53, pp.25~30 (1987)
- Barnett PV, "International bank for foot-and-mouth disease vaccine: assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants", Vaccine, 14, pp.1187~1196 (1996)
- 최성현, "Economic burden of foot-and-mouth disease vaccination-induced injection site lesions in slaughtered pigs and its causal relationship", 예방수의학회지, 39(4), pp.153~156 (2015), 한국예방수의학회[DOI]
- Hyun BH, "Development and evaluation of a vaccine stress reliever for pigs", 5th Vaccine and ISV annual Global Congress Proceeding, pp.3~ (2011)
- Jamel SM, "Food-and-mouth disease: past, present and future", Vet Res, 44, pp.116~ (2013)
- Research report on causal analysis of injection site tissue reaction due to foot-and-mouth disease vaccination and mitigation strategy, "Jeong HK", Dodramnonghyup, 62~67 (2012)
- Kim T, "Effect of injection tool on incidence of head and neck abscesses at slaughter", J Swine Health Prod, 18, pp.290~293 (2010)
- Knowles NJ, "Molecular epidemiology of foot-and-mouth disease virus", Virus Res, 91, pp.65~80 (2003)
- Mckercher PD, "Reaction of swine to oil-adjuvanted inactivated foot-andmouth disease virus vaccine inoculated by intramuscular and subcutaneous routes", Archiv für die gesamte Virusforschung, 35, pp.364~377 (1971)
- Miller WH Jr, "Efficacy of chlorpheniramine maleate for management of pruritus in cats", J Am Vet Med Assoc, 197, pp.67~70 (1990)
- Oda K, "Emulsifier content and side effects of oil-based adjuvant vaccine in swine", Res Vet Sci, 81, pp.51~57 (2006)
- Office International des Epizooties, "Foot and Mouth Disease, OIE Terrestrial Mannual (Chapter 2.1.8)", 1~31 (2016)
- "Weekly Disease Information" (2017)[URL]
- Park JH, "Reemergence of foot-and-mouth disease, South Korea, 2000-2011", Emerg Infect Dis, 20, pp.2158~2161 (2014)
- Park JH, "Control of foot-andmouth disease during 2010-2011 epidemic, South Korea", Emerg Infect Dis, 19, pp.655~659 (2013)
- 박종현, "Novel foot-and-mouth disease virus in Korea, July-August 2014", Clinical and Experimental Vaccine Research, 5(1), pp.83~87 (2016), 대한백신학회
- Parker R, "Adjuvant formulation for veterinary vaccines: MontanideTM Gel safety profile", Procedia in Vaccinology, 1, pp.140~147 (2009)
- Shin JH, "Identification and isolation of foot-and-mouth disease virus from primary suspect cases in Korea in 2000", J Vet Med Sci, 65, pp.1~7 (2003)
- Singh M, "Recent advances in veterinary vaccine adjuvants", Inter J Parasitol, 33, pp.469~478 (2003)
- Stewart-Tull, D.E.S., "The Theory and Practical Application of Adjuvants" (1995), Wiley
- Straw BE, "Comparison of tissue reactions produced by Haemophilus pleuropneumoniae vaccines made with six different adjuvants in swine", Can J Comp Med, 49, pp.149~151 (1985)
- Tizard IR, "Veterinary immunology. An introduction" (2000), W.B. Saunders Company
- Valtulini S, "Aluminium hydroxide-induced granulomas in pigs", Vaccine, 23, pp.3999~4004 (2005)
- Wee SH, "Control measures implemented during the 2002 foot-and-mouth disease outbreak in the Republic of Korea", Vet Rec, 154, pp.598~600 (2004)
- Yeruham I, "Adverse reactions to FMD vaccine", Vet Dermatol, 12, pp.197~201 (2001)